Daniel J Olson (Daniel Olson)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Immune Response

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Robin Reschke, Daniel J Olson
Correction: Reschke, R.; Olson, D.J. Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. Cancers 2022, 14 , 2458. Cancers 16 (6) (2024)
Robin Reschke, Daniel J Olson
Correction: Reschke, R.; Olson, D.J. Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce a "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. Cancers 2022, 14 , 2458. Cancers 16 (6) (2024)
Daniel J Olson, Jason John Luke
Myeloid maturity: ATRA to enhance anti-PD-1? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Daniel J Olson, Jason John Luke
Myeloid maturity: ATRA to enhance anti-PD-1? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Aws Hammad, Osmanuddin Ahmed, Philip P Connell, Daniel J Olson, Tessa Balach
Team Approach: Management of Pathologic Fractures. JBJS reviews 11 (1) (2023)
Daniel J Olson, Kunle Odunsi
Adoptive Cell Therapy for Nonhematologic Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Aws Hammad, Osmanuddin Ahmed, Philip P Connell, Daniel J Olson, Tessa Balach
Team Approach: Management of Pathologic Fractures. JBJS reviews 11 (1) (2023)
Daniel J Olson, Jason John Luke
Myeloid maturity: ATRA to enhance anti-PD-1? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Aws Hammad, Osmanuddin Ahmed, Philip P Connell, Daniel J Olson, Tessa Balach
Team Approach: Management of Pathologic Fractures. JBJS reviews 11 (1) (2023)
Daniel J Olson, Jason John Luke
Myeloid maturity: ATRA to enhance anti-PD-1? Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Aws Hammad, Osmanuddin Ahmed, Philip P Connell, Daniel J Olson, Tessa Balach
Team Approach: Management of Pathologic Fractures. JBJS reviews 11 (1) (2023)
Sherin Juliet Rouhani, Jovian Yu, Daniel J Olson, Yuanyuan Zha, Apameh Pezeshk, Alexandra Cabanov, Athalia R Pyzer, Jonathan Trujillo, Benjamin A Derman, Peter O'Donnell, Andrzej Jakubowiak, Hedy L Kindler, Christine Bestvina, Thomas F Gajewski
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies. Journal for immunotherapy of cancer 10 (6) (2022)
Robin Reschke, Daniel J Olson
Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A "Hot" Tumor Microenvironment That Is Responsive to Immunotherapy. Cancers 14 (10) (2022)
Robin Reschke, Jason W Shapiro, Jovian Yu, Sherin Juliet Rouhani, Daniel J Olson, Yuanyuan Zha, Thomas F Gajewski
Checkpoint Blockade-Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines. Cancer immunology research 10 (10) (2022)
Daniel J Olson, Zeynep Eroglu, Bruce E Brockstein, Andrew S Poklepovic, Madhuri Bajaj, Sunil Babu, Sigrun Hallmeyer, Mario Velasco, Jose Lutzky, Emily F Higgs, Riyue Bao, Timothy Clifford Carll, Brian Labadie, Thomas Krausz, Yuanyuan Zha, Theodore Karrison, Vernon K Sondak, Thomas F Gajewski, Nikhil I Khushalani, Jason John Luke
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (24) (2021)
Thomas U Marron, Aideen E Ryan, Sangeetha M Reddy, Sabina Kaczanowska, Rania H Younis, Dipti Thakkar, Jiajia Zhang, Todd Bartkowiak, Rachel Howard, Kristin G Anderson, Daniel J Olson, Abdul Rafeh Naqash, Ravi B Patel, Esha Sachdev, Maria E Rodriguez-Ruiz, Michal Sheffer, Sarah Church, Christopher Fuhrman, Abigail Overacre-Delgoffe, Rosa Nguyen, Vaia Florou, Jessica E Thaxton, David H Aggen, Jennifer L Guerriero
Considerations for treatment duration in responders to immune checkpoint inhibitors. Journal for immunotherapy of cancer 9 (3) (2021)
Daniel J Olson, Padma Rajagopal, Melissa Y Tjota, Girish Venkataraman, Jason J Luke, Thomas F Gajewski
A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab. Journal for immunotherapy of cancer 8 (1) (2020)